Major Surgical or Invasive Procedure: Brain biopsy [**2111-2-23**] Central line placement [**2111-2-28**] Portacath placement [**2111-3-12**] G-tube placement [**2111-3-12**]  History of Present Illness: This is a 73 year old female with history of alcohol abuse, cirrhosis, bipolar disorder, and hypothyroidism, who was transferred to [**Hospital1 18**] with mental status change, aphasia, left sided weakness and facial droop, and encephalopathy.
Pertinent Results: Labs on admission: [**2111-2-18**] 09:35PM   AMMONIA-11* [**2111-2-18**] 06:50PM URINE  HOURS-RANDOM [**2111-2-18**] 06:50PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2111-2-18**] 06:50PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]->1.050 [**2111-2-18**] 06:50PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG [**2111-2-18**] 06:08PM   LACTATE-1.0 [**2111-2-18**] 06:00PM   GLUCOSE-128* UREA N-19 CREAT-0.8 SODIUM-141 POTASSIUM-4.3 CHLORIDE-103 TOTAL CO2-29 ANION GAP-13 [**2111-2-18**] 06:00PM   estGFR-Using this [**2111-2-18**] 06:00PM   ALT(SGPT)-6 AST(SGOT)-12 LD(LDH)-142 CK(CPK)-30 ALK PHOS-80 TOT BILI-0.3 [**2111-2-18**] 06:00PM   CK-MB-2 cTropnT-<0.01 [**2111-2-18**] 06:00PM   TSH-0.88 [**2111-2-18**] 06:00PM   T3-62* FREE T4-1.2 [**2111-2-18**] 06:00PM   PHENYTOIN-9.3* VALPROATE-41* [**2111-2-18**] 06:00PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2111-2-18**] 06:00PM   WBC-7.5 RBC-3.57* HGB-12.4 HCT-35.8* MCV-100* MCH-34.9* MCHC-34.8 RDW-12.7 [**2111-2-18**] 06:00PM   NEUTS-84.3* LYMPHS-10.3* MONOS-3.6 EOS-1.3 BASOS-0.4 [**2111-2-18**] 06:00PM   PLT COUNT-432 [**2111-2-18**] 06:00PM   PT-14.2* PTT-28.7 INR(PT)-1.2*  Labs on discharge: [**2111-3-18**] 12:00AM BLOOD WBC-3.4* RBC-2.72* Hgb-9.3* Hct-27.2* MCV-100* MCH-34.1* MCHC-34.1 RDW-14.1 Plt Ct-368 [**2111-3-18**] 12:00AM BLOOD Glucose-100 UreaN-21* Creat-0.3* Na-132* K-4.1 Cl-101 HCO3-26 AnGap-9 [**2111-3-17**] 12:00AM BLOOD ALT-37 AST-17 LD(LDH)-146 AlkPhos-60 TotBili-0.3 [**2111-3-18**] 12:00AM BLOOD Calcium-8.8 Phos-2.9 Mg-2.0  Tissue pathology [**2111-2-23**]: A)  "-5":  Gliotic brain tissue.
"-2":  Smear - Gliotic brain possibly with some necrosis.
G)  "Right brain lesion":  Minute fragment of atypical glial cells, inflammatory cells and necrosis.
There is a diffuse dense infiltrate of atypical mononuclear cells comprised of predominantly large cells, within finely dispersed chromatin and multiple small nucleoli.
There are focal areas of necrosis/apoptosis, frequent mitosis as well as perivascular cuffing noted (see slide F).
Reticulin stain highlights multiple vessel walls.
Video swallow [**2111-3-13**]: Moderate oropharyngeal dysphagia, including aspiration of thin liquid.
Patient should repeat bedside swallow evaluation in one to two weeks.
She was diuresed and started on vanc/unasyn on [**2111-3-4**] for aspiration.
The patient received a G-tube and PORT placement on [**2111-3-12**].
She also received her second round of Methotrexate chemotherapy after these procedures and Methotrexate levels followed until clear.
She will be returning in two-weeks for her next methotrexate treatment.
Synthroid 88 mcg daily 2. depakote 250mg daily 3.
Ativan prn 4. lasix 20mg daily 5. folate 1mg daily 6.
Colace 100mg [**Hospital1 **] 9.
Prilosec 20mg [**Hospital1 **] 10.
MOM prn 11.
Dulcolax prn  Discharge Medications: 1.
Dexamethasone 2 mg Tablet Sig: One (1) Tablet PO once a day: Give by g-tube.
Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day): DVT prophylaxis.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed: give by g-tube.
Insulin Regular Human 100 unit/mL Solution Sig: sliding scale  Injection ASDIR (AS DIRECTED).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day) as needed.
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Polyethylene Glycol 3350 100 % Powder Sig: Seventeen (17) g PO DAILY (Daily) as needed.
Midodrine 5 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID (3 times a day) as needed.
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed.
Famotidine 20 mg IV Q12H 17.
LeVETiracetam 1000 mg IV BID 18.
Lorazepam 0.5-2 mg IV Q4H:PRN for sz > 3 min or 3 per hour 19.
Heparin Flush (10 units/ml) 1 mL IV PRN line flush Temporary Central Access-Floor:    Flush with 10 mL Normal Saline followed by Heparin as above daily and PRN.
Heparin Flush (10 units/ml) 5 mL IV PRN line flush Indwelling Port (e.g.
Portacath), heparin dependent: Flush with 10 mL Normal Saline followed by Heparin as above daily and PRN per lumen.
Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port Indwelling Port (e.g.
Portacath), heparin dependent: When de-accessing port, instill Heparin as above per lumen.
This was treated with neurosurgery and two rounds of chemotherapy (methotrexate).
You are scheduled to return in two weeks for your next round of chemotherapy (see appointment below).
In the meantime, you will continue your physical therapy and rehabilitation.
